Associated Papers
Integrative structural profiling and ligand optimisation across the transthyretin mutational landscape.
Lomoio U et al.
Npj Systems Biology and Applications, 2025
40998828 (PubMed )
Supplement: 41540_2025_582_MOESM1_ESM.pdf
Cellular secretion and cytotoxicity of transthyretin mutant proteins underlie late-onset amyloidosis and neurodegeneration.
Ibrahim RB et al.
Cellular and Molecular Life Sciences : Cmls, 2020
[Hereditary and acquired transthyretin-mediated amyloidosis].
van der Bie MH et al.
Nederlands Tijdschrift Voor Geneeskunde, 2020
A pair of peptides inhibits seeding of the hormone transporter transthyretin into amyloid fibrils.
Saelices L et al.
The Journal of Biological Chemistry, 2019
Abnormal small bowel motility in patients with hereditary transthyretin amyloidosis.
Wixner J et al.
Neurogastroenterology and Motility, 2018
Frequency of and Prognostic Significance of Cardiac Involvement at Presentation in Hereditary Transthyretin-Derived Amyloidosis and the Value of N-Terminal Pro-B-Type Natriuretic Peptide.
Klaassen SHC et al.
The American Journal of Cardiology, 2018
Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).
Klaassen SHC et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology, 0
Select a paper to view details